GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theraclion (XPAR:ALTHE) » Definitions » Institutional Ownership

Theraclion (XPAR:ALTHE) Institutional Ownership : 0.65% (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Theraclion Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Theraclion's institutional ownership is 0.65%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Theraclion's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Theraclion's Float Percentage Of Total Shares Outstanding is 0.00%.


Theraclion Institutional Ownership Historical Data

The historical data trend for Theraclion's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theraclion Institutional Ownership Chart

Theraclion Historical Data

The historical data trend for Theraclion can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.63 0.63 0.63 0.59 0.59 0.59 0.64 0.65 0.65 0.65

Theraclion Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Theraclion (XPAR:ALTHE) Business Description

Traded in Other Exchanges
N/A
Address
102, rue Etienne Dolet, Malakoff, FRA, 92240
Theraclion is a France-based company specializing in high-tech therapeutic ultrasound equipment. The product, Echopulse, helps in the treatment of breast fibroadenomas and benign thyroid nodules.

Theraclion (XPAR:ALTHE) Headlines

No Headlines